Sunny P. Kumar

CN-6, Sector V, Salt Lake
Kolkata, WB 700091, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Targeting USP7 - a nano-therapeutic approach to restore and reactivate P53 for promoting apoptosis in glioma therapy.

Targeting USP7 - a nano-therapeutic approach to restore and reactivate P53 for promoting apoptosis in glioma therapy.

Journal: Nanomedicine (London, England)

Published: July 17, 2026

Dual PLGA nanoparticles co-encapsulating P5091 and Resveratrol synergistically target the USP7-MDM2-P53 axis for glioma therapy.

Dual PLGA nanoparticles co-encapsulating P5091 and Resveratrol synergistically target the USP7-MDM2-P53 axis for glioma therapy.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: February 18, 2026

Nanomedicines: an update of diagnostic and therapeutic applications in multiple cancers.

Nanomedicines: an update of diagnostic and therapeutic applications in multiple cancers.

Journal: Journal of drug targeting

Published: January 05, 2026

Phytochemical profiling of Andrographis beddomei C.B. Clarke using UHPLC-ORBITRAP-MS/MS approach and assessment of cytotoxicity in cisplatin-resistant ovarian cancer.

Phytochemical profiling of Andrographis beddomei C.B. Clarke using UHPLC-ORBITRAP-MS/MS approach and assessment of cytotoxicity in cisplatin-resistant ovarian cancer.

Journal: Natural product research

Published: November 03, 2025

Isoquinolinone-Naphthoquinone Hybrids as Potent PARP-1 Inhibitors Induce Apoptosis in Glioma via DNA Damage and ROS Generation.

Isoquinolinone-Naphthoquinone Hybrids as Potent PARP-1 Inhibitors Induce Apoptosis in Glioma via DNA Damage and ROS Generation.

Journal: Journal of medicinal chemistry

Published: September 11, 2025

Hypoxia-driven metabolic and molecular reprogramming: From tumor microenvironment to therapeutic interventions.

Hypoxia-driven metabolic and molecular reprogramming: From tumor microenvironment to therapeutic interventions.

Journal: Pathology, research and practice

Published: September 08, 2025

β-catenin: A crucial transcriptional activator of KSHV latency genes and small molecule target in primary effusion lymphoma.

β-catenin: A crucial transcriptional activator of KSHV latency genes and small molecule target in primary effusion lymphoma.

Journal: Virology

Published: August 29, 2025

Strain-specific mutagenicity of NDMA and CPNP: insights from TA1535, TA100, and WP2 uvrA (pKM101) under metabolic activation.

Strain-specific mutagenicity of NDMA and CPNP: insights from TA1535, TA100, and WP2 uvrA (pKM101) under metabolic activation.

Journal: Environmental toxicology and pharmacology

Published: June 02, 2025

Role of ETS2 gene in inflammatory bowel disease: A narrative review.

Role of ETS2 gene in inflammatory bowel disease: A narrative review.

Journal: Medicine

Published: May 28, 2025

CHIP modulates Wnt/β-catenin signalling in colorectal cancer through proteasomal degradation of DDX17.

CHIP modulates Wnt/β-catenin signalling in colorectal cancer through proteasomal degradation of DDX17.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: May 21, 2025

A dynamically crosslinked, self-adapting, injectable gelatin-chondroitin sulfate hydrogel with antibacterial and antioxidant properties for treatment of deep and irregular wounds.

A dynamically crosslinked, self-adapting, injectable gelatin-chondroitin sulfate hydrogel with antibacterial and antioxidant properties for treatment of deep and irregular wounds.

Journal: Journal of materials chemistry. B

Published: May 14, 2025

Identification of a novel p65-p68 loop: A crucial determinant for p68 gene regulation in oncogenesis.

Identification of a novel p65-p68 loop: A crucial determinant for p68 gene regulation in oncogenesis.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms

Published: May 13, 2025

Showing 1-12 of 33

Last Updated: 09/26/2026